Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease

Journal of Inorganic Biochemistry

Volumn 79, Issue 1-4, 2000, Pages 319-326

  Linert, W ^a   Jameson, G N L ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

6 Hydroxydopamine; Fenton reaction; Ferritin; Oxidative stress; Parkinsonism

Indexed keywords

CATECHOLAMINE; DOPAMINE; FERRITIN; OXIDOPAMINE;

ARTICLE; DEGENERATIVE DISEASE; DOPAMINE METABOLISM; HUMAN; IRON STORAGE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

CATECHOLAMINES; DISEASE PROGRESSION; DOPAMINE; FERRITINS; HUMANS; HYDROXYL RADICAL; IRON; NEUROTRANSMITTER AGENTS; OXIDATION-REDUCTION; PARKINSON DISEASE;

EID: 0034732614     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00238-X     Document Type: Article

References (54)

1. Hirsch E.C. Ann. Neurol. 32:1992;88-93.
2. Kastner A., Hirsch E.C., Lejeune O., Javoy-Agid F., Rascol O., Agid Y. J. Neurochem. 59:1992;1080-1089.
3. Fearnley J.M., Lees A.J. Brain. 114:1991;2289-2301.
4. B. Halliwell, in: L. Packer, L. Prilipko, Y. Christen (Eds.), Free Radicals in The Brain, Ageing, Neurological, Mental Disorders, Springer, Berlin, 1992, pp. 21-40.
5. Turski L., Bressler K., Rettig K.J., Loschman P.A., Wachtel H. Nature. 349:1991;414-418.
6. Riederer P., Dirr A., Goetz M., Sofic E., Jellinger K., Youdim M.B.H. Ann. Neurol. 32:1992;101-104.
7. Youdim M.B.H., Ben-Schachar D., Riederer P. Mov. Disord. 8:1993;1-12.
8. Jenner P. Acta Neurol. Scand. 84(Suppl. 136):1991;6-15.
9. Griffiths P.D., Crossmann A.R. Dementia. 4:1993;61.
10. Jellinger K.A., Kienzl E., Rumplmair G., Paulus W., Riederer P., Stachgelberger H., Ben-Shachar D., Youdim M.B.H. J. Neurochem. 59:1992;1168.
11. Jellinger K.A. Drugs Ageing. 14:1999;1.
12. Linert W., Jameson R.F., Herlinger E. Inorg. Chim. Acta. 187:1991;239-247.
13. Linert W., Herlinger E., Jameson R.F. J. Chem. Soc., Perkin Trans. 2:1993;2435-2439.
14. U. El-Ayaan, E. Herlinger, R.F. Jameson, W. Linert, J. Chem. Soc., Dalton Trans. (1997) 2813-2818.
15. U. El-Ayaan, R.F. Jameson, W. Linert, J. Chem. Soc., Dalton Trans. (1998) 1315-1319.
16. E. Herlinger, R.F. Jameson, W. Linert, J. Chem. Soc., Perkin Trans. (1995) 259-263.
17. Heacock R.A. Chem. Rev. 59:1959;181-237.
18. Heist R.H., Roe A.L., Que Jr L. Inorg. Chem. 21:1982;676-681.
19. Que Jr L. Coord. Chem. Rev. 50:1983;73-108.
20. R.F. Jameson, T. Kiss, J. Chem. Soc., Dalton Trans (1986) 1833-1838.
21. Swartz H.M., Sarna T., Zecca L. Ann. Neurol. 32:1992;S69-S75.
22. Herlinger E., Jameson R.F. J. Inorg. Biochem. 59:1995;622.
23. Linert W., Herlinger E., Jameson R.F., Kienzl E., Jellinger K., Youdim M.B.H. Biochim. Biophys. Acta. 1316:1996;160-169.
24. G.N.L. Jameson, Ph.D. Thesis, T.U. Wien, 1999.
25. Mure M., Klinman J.P. J. Am. Chem. Soc. 116:1994;8698-8706.
26. Fenton H.J.H. J. Chem. Soc. 65:1894;899-910.
27. Haber F., Weiss J. Proc. R. Soc. London, Ser. B. 147:1934;332-351.
28. Uri N. Chem. Rev. 50:1952;375-454.
29. Goldstein S., Meyerstein D., Czapski G. Medicine. 15:1993;435-445.
30. Linert W., Bridge M.H., Huber M., Bjugstad K.B., Grossman S., Arendash G.W. Biochim. Biophys. Acta. 1454:1999;143.
31. Andrew R., Watson D.G., Best S.A., Midgley J.M., Wenlong H., Petty R.K.H. Neurochem. Res. 18:1993;1175-1177.
32. R.R. Crichton, Inorganic Biochemistry of Iron Metabolism, Elis Horwood, Chichester, UK, 1991.
33. Jones T., Spencer R., Walsh C. Biochemistry. 17:1978;4011-4017.
34. Dognin J., Crichton R.R. FEBS Lett. 54:1975;234-236.
35. Double K.L., Maywald M., Schmittel M., Riederer P., Gerlach M. J. Neurochem. 70:1998;2492-2499.
36. Monteiro H.P., Winterbourn C.C. Biochem. Pharmacol. 38:1989;4177-4182.
37. Ben-Shachar D., Eshel G., Finberg J.P.M., Youdim M.B.H. J. Neurochem. 56:1991;1441-1444.
38. G.N.L. Jameson, unpublished work.
39. Palumbo A., d'Ischia M., Misuraca G., De Martino L., Prota G. Biochim. Biophys. Acta. 1245:1995;255-261.
40. Fornstedt B., Bergh I., Rosengren E., Carlsson A. J. Neurochem. 54:1990;578-586.
41. B. Fornstedt, A. Brun, E. Rosengren, A. Carlsson, J. Neural Transm. 1 (P-D section) (1989) 279-295.
42. Jenner P., Dexter D.T., Sian J., Schapira A.H.V., Marsden C.D. Ann. Neurol. (Suppl.). 32:1992;S82-S87.
43. Zhang F., Dryhurst G. J. Med. Chem. 37:1994;1084-1098.
44. Kienzl E., Puchinger L., Jellinger K., Linert W., Stachelberger H., Jameson R.F. J. Neurol. Sci. (Suppl.). 134:1995;69-78.
45. M.J.Bjerrum, personal communications.
46. Dexter D.T., Jenner P., Schapira A.H.V., Marsden C.D. Ann. Neurol. 32:1992;94-100.
47. K. Jellinger, E. Kienzl, in: P. Riederer, M.B.H. Youdim (Eds.), Iron in Central Nervous System Disorders, Springer, Vienna, 1993, pp. 19-36.
48. G.N.L. Jameson, W. Linert, in: G. Poli, E. Cadenas, L. Packer (Eds.), Free Radicals in Brain Pathophysiology, Marcel Dekker, New York, 1999.
49. W. Linert, K. Jellinger, in: J. Seguara-Aguilar (Ed.), The Role of Reactive Catecholamine Species in Neurodegeneration, Apoptosis of Dopamineric Neurons, Salzburger and Graham Publishing, in press.
50. Steenken S., Neta P. J. Phys. Chem. 86:1982;3661-3667.
51. Double K.L., Maywald M., Schmittel M., Riederer P., Gerlach M. J. Neurochem. 7:1998;2492-2499.
52. Mentasti E., Pelizzetti E., Giraudi G. Z. Phys. Chem. 100:1976;17-23.
53. Blank C.L., McCreery R.L., Wightman R.M., Chey W., Adams R.N., Reid J.R., Smissman E.E J. Med. Chem. 19:1976;178-180.
54. A.C. Cheng, N. Castagnoli Jr, J. Med. Chem. 27 (1984) 513-520, and unpublished NMR studies carried out by this group.